相关实验视频
Updated: Jul 11, 2025

16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
24.9K
在败血症休克患者的限制性液体复苏中,死亡率和器官功能障碍率低于标准疗法
Zhizhao Jiang1, Fenbin Luo, Yuqi Liu
1Department of Intensive Care Unit, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, People's Republic of China.
Shock (Augusta, Ga.)
|November 14, 2023
概括
在败血症休克患者中,限制性液体复苏和早期血管压缩剂显著降低了死亡率和器官功能障碍. 这种方法是可行的和安全的,改善了临床结果,减少了重症监护室的停留时间.
科学领域:
- 临界护理医学 临界护理医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 紧急医疗 紧急医疗
背景情况:
- 对于败血症休克的最佳液体复苏策略仍在争论中.
- 早期使用血管压缩剂是常见的,但其与流体管理的相互作用尚不清楚.
- 了解这些干预措施对死亡率和器官功能障碍的影响至关重要.
研究的目的:
- 评估限制性流体管理对败血症休克患者死亡率和器官功能障碍的影响.
- 为了比较限制性和标准液体复苏策略之间的临床结果.
主要方法:
- 一项对连续感染性休克患者的比较研究,需要进行液体复苏.
- 根据最初的复苏,患者被分为限制性或标准流体管理组.
- 主要结局是住院死亡率;次要结局包括器官功能障碍和不良事件.
主要成果:
- 限制性流体管理与显著降低住院死亡率 (24.8%与52.6%) 和更短的ICU停留时间有关.
- 限制性策略减少了急性损伤的发生率 (25.5%与51.5%) 和需要替代疗法 (20.6%与40.2%).
- 限制性组中需要机械通风的患者较少,并且他们有更多的无血管压缩剂日.
结论:
- 限制性液体复苏与早期血管压缩剂的管理相结合,改善了性休克的结果.
- 这种联合疗法与降低死亡率,器官功能障碍和更短的重症监护病房停留有关.
- 研究结果表明,这种方法是一种可行且安全的策略,用于管理败血症休克.
相关概念视频
Acute Respiratory Failure-V
143
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
143
Acute Kidney Injury V: Interprofessional Care
11
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
11
Heart Failure Drugs: Diuretics
400
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
400
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Cardiopulmonary Resuscitation IV: Pharmacological Management
12
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
12
Continuous Renal Replacement Therapy
38
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
38

